SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016023
Filing Date
2022-08-09
Accepted
2022-08-09 16:02:57
Documents
85
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q eftr-20220630.htm   iXBRL 10-Q 2768217
2 EX-10.2 eftr-ex10_2.htm EX-10.2 102770
3 EX-10.3 eftr-ex10_3.htm EX-10.3 97640
4 EX-10.4 eftr-ex10_4.htm EX-10.4 102052
5 EX-31.1 eftr-ex31_1.htm EX-31.1 20698
6 EX-31.2 eftr-ex31_2.htm EX-31.2 20657
7 EX-32.1 eftr-ex32_1.htm EX-32.1 11655
8 EX-32.2 eftr-ex32_2.htm EX-32.2 11620
  Complete submission text file 0000950170-22-016023.txt   11547241

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eftr-20220630.xsd EX-101.SCH 86798
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eftr-20220630_pre.xml EX-101.PRE 489654
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eftr-20220630_def.xml EX-101.DEF 354602
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eftr-20220630_cal.xml EX-101.CAL 45170
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eftr-20220630_lab.xml EX-101.LAB 625369
79 EXTRACTED XBRL INSTANCE DOCUMENT eftr-20220630_htm.xml XML 2163665
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39866 | Film No.: 221148157
SIC: 2834 Pharmaceutical Preparations